GSK shares tumble after Delaware court ruling on Zantac - Financial Times
WEBJun 3, 2024 · GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
GSK asks to appeal Delaware ruling allowing Zantac cases to go …
WEBJun 10, 2024 · GSK and other drugmakers on Monday asked a Delaware court for permission to appeal a ruling allowing more than 70,000 lawsuits claiming that heartburn drug Zantac causes cancer to go forward.
Boehringer Ingelheim Faces Second Hung Jury in Chicago Zantac …
WEB3 days ago · By Brendan Pierson. (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...
GSK set to face jury trials over heartburn drug Zantac - Financial Times
WEBJun 1, 2024 · The ruling by Judge Vivian Medinilla means that scientific experts will be able to testify before a jury that there is a link between the plaintiffs’ cancers and their exposure to NDMA, a probable...
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by …
WEBJul 1, 2024 · A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.
GSK soothes investors by settling first Zantac cancer lawsuit due …
WEBJun 23, 2023 · GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug Zantac caused cancer, the British drugmaker said on Friday, preventing the first such case from going to trial next...
Victory for drugmakers GSK and Boehringer in $640 million Zantac …
WEBMay 24, 2024 · Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a woman’s claim that the blockbuster heartburn drug Zantac caused her cancer, handing the companies a win in ...
Pfizer offers up to $250mn to settle thousands of Zantac cancer …
WEBMay 16, 2024 · Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated with its now-discontinued heartburn drug Zantac, according to people familiar with the...
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Suits
WEBMay 8, 2024 · Pfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the...
Zantac Lawsuit: Status, Eligibility, & Settlements - Drugwatch
WEBSep 3, 2024 · People who took Zantac made with ranitidine and developed cancer filed lawsuits after manufacturers issued ranitidine and Zantac recalls for the potential risk of cancer. FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen.
Skip to content